1. Home
  2. OLMA vs DCGO Comparison

OLMA vs DCGO Comparison

Compare OLMA & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • DCGO
  • Stock Information
  • Founded
  • OLMA 2006
  • DCGO 2015
  • Country
  • OLMA United States
  • DCGO United States
  • Employees
  • OLMA N/A
  • DCGO N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • DCGO Managed Health Care
  • Sector
  • OLMA Health Care
  • DCGO Health Care
  • Exchange
  • OLMA Nasdaq
  • DCGO Nasdaq
  • Market Cap
  • OLMA 420.2M
  • DCGO 415.2M
  • IPO Year
  • OLMA 2020
  • DCGO N/A
  • Fundamental
  • Price
  • OLMA $5.66
  • DCGO $4.17
  • Analyst Decision
  • OLMA Strong Buy
  • DCGO Strong Buy
  • Analyst Count
  • OLMA 5
  • DCGO 5
  • Target Price
  • OLMA $26.25
  • DCGO $6.10
  • AVG Volume (30 Days)
  • OLMA 1.3M
  • DCGO 551.0K
  • Earning Date
  • OLMA 03-10-2025
  • DCGO 02-26-2025
  • Dividend Yield
  • OLMA N/A
  • DCGO N/A
  • EPS Growth
  • OLMA N/A
  • DCGO 300.38
  • EPS
  • OLMA N/A
  • DCGO 0.29
  • Revenue
  • OLMA N/A
  • DCGO $694,968,328.00
  • Revenue This Year
  • OLMA N/A
  • DCGO $2.14
  • Revenue Next Year
  • OLMA N/A
  • DCGO N/A
  • P/E Ratio
  • OLMA N/A
  • DCGO $14.62
  • Revenue Growth
  • OLMA N/A
  • DCGO 30.19
  • 52 Week Low
  • OLMA $4.60
  • DCGO $2.75
  • 52 Week High
  • OLMA $16.78
  • DCGO $4.86
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 41.95
  • DCGO 48.53
  • Support Level
  • OLMA $4.60
  • DCGO $3.95
  • Resistance Level
  • OLMA $5.83
  • DCGO $4.41
  • Average True Range (ATR)
  • OLMA 0.54
  • DCGO 0.19
  • MACD
  • OLMA 0.15
  • DCGO -0.02
  • Stochastic Oscillator
  • OLMA 59.55
  • DCGO 45.00

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.

Share on Social Networks: